Susquehanna International Group’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.25M Sell
161,136
-6,061
-4% -$84.8K ﹤0.01% 2149
2025
Q1
$2.27M Buy
167,197
+95,957
+135% +$1.3M ﹤0.01% 2119
2024
Q4
$1.45M Buy
71,240
+21,070
+42% +$429K ﹤0.01% 2420
2024
Q3
$1.46M Sell
50,170
-10,228
-17% -$298K ﹤0.01% 2230
2024
Q2
$1.4M Sell
60,398
-44,242
-42% -$1.03M ﹤0.01% 2147
2024
Q1
$2.15M Buy
104,640
+43,726
+72% +$897K ﹤0.01% 1734
2023
Q4
$1.31M Sell
60,914
-32,889
-35% -$706K ﹤0.01% 2480
2023
Q3
$1.94M Sell
93,803
-23,789
-20% -$491K ﹤0.01% 1864
2023
Q2
$3.47M Sell
117,592
-222,972
-65% -$6.58M ﹤0.01% 1384
2023
Q1
$7.85M Buy
340,564
+317,311
+1,365% +$7.31M ﹤0.01% 856
2022
Q4
$647K Sell
23,253
-73,374
-76% -$2.04M ﹤0.01% 2860
2022
Q3
$2.97M Buy
96,627
+86,101
+818% +$2.64M ﹤0.01% 1280
2022
Q2
$310K Sell
10,526
-75,192
-88% -$2.21M ﹤0.01% 3953
2022
Q1
$2.76M Sell
85,718
-33,177
-28% -$1.07M ﹤0.01% 1679
2021
Q4
$5.3M Buy
118,895
+66,798
+128% +$2.98M ﹤0.01% 1140
2021
Q3
$2.63M Buy
52,097
+32,872
+171% +$1.66M ﹤0.01% 1688
2021
Q2
$1.51M Buy
19,225
+4,101
+27% +$322K ﹤0.01% 2410
2021
Q1
$864K Sell
15,124
-9,996
-40% -$571K ﹤0.01% 3169
2020
Q4
$2.1M Buy
25,120
+8,737
+53% +$732K ﹤0.01% 1684
2020
Q3
$587K Buy
16,383
+3,700
+29% +$133K ﹤0.01% 2851
2020
Q2
$307K Sell
12,683
-27,441
-68% -$664K ﹤0.01% 3372
2020
Q1
$703K Buy
+40,124
New +$703K ﹤0.01% 2461
2019
Q4
Sell
-59,852
Closed -$917K 4162
2019
Q3
$917K Buy
59,852
+21,927
+58% +$336K ﹤0.01% 2120
2019
Q2
$787K Buy
+37,925
New +$787K ﹤0.01% 2381
2018
Q3
Hold
0
3635
2018
Q2
Hold
0
3853